Development and initial validation of the ‘Bristol Impact of Hypermobility’ (BIoH) questionnaire ST Palmer a, F Cramp a, R Lewis b, G Gould c, E Clark.

Slides:



Advertisements
Similar presentations
"What I really needed was the truth" Exploring the information needs of people with CRPS. Sharon Grieve 1,2, Jo Adams 2, Candida McCabe 1,3. 1 Royal National.
Advertisements

Diagnosis, management & assessment of adults with joint hypermobility syndrome: UK-wide survey of physiotherapy practice Shea Palmer a, Fiona Cramp a,
Izaguirre A, Olivos A, Ibarra C, Marx R.
Improving health outcomes across England by providing improvement and change expertise How to Measure Patient Activation Measuring Patient Activation In.
Authors and affiliation Research, University of Sheffield, 3 East Midlands Ambulance Service Study flow Conclusion In addition to measures relating to.
DEVELOPMENT OF A PREFERENCE-BASED, CONDITION SPECIFIC PATIENT REPORTED OUTCOME MEASURE FOR USE WITH VENOUS ULCERATION Simon Palfreyman 1, John E Brazier.
Patients with Rheumatoid Arthritis in Comparison to Other Connective Tissue Diseases Are Mostly Influenced by Concomitant Fibromyalgia Tomš J, Daňková.
A Comparative Analysis of Croatian Immigrant's and the Australian Population's subjective quality of life and self-perceived health status Gorka Vuletić.
Health-related quality of life in diabetic patients and controls without diabetes in refugee camps in Gaza strip: a cross-sectional study By: Ashraf Eljedi:
Cross-Cultural Use of Measurements: Development of the Chinese SF-36 Health Survey Xinhua S. Ren, Ph.D. Boston University School of Public Health, Boston,
Health related quality of life and satisfaction with life in Croatia Gorka Vuletic, BPsychol, PhD Andrija Stampar School of Public Health Medical Faculty,
In the name of Allah. Development and psychometric Testing of a new Instrument to Measure Affecting Factors on Women’s Behaviors to Breast Cancer Prevention:
Quality of Life in Oporto and South of Douro Region – Comparison of EQ-5D and SF-36 Introdução à Medicina Turma 6 – 2006/2007.
Self-Report Measures of Functional Status and Quality of Life: Adults Sandra A. Mitchell, CRNP, M.Sc.N., AOCN National Institutes of Health Bethesda, MD.
Daniel Flynn 1, Mary Kells 1, Mary Joyce 1&2, Catalina Suarez 1&2 1. Health Service Executive 2. National Suicide Research Foundation The National Dialectical.
CHEN Program Assessment Advisory Board Meeting June 3 rd, 2012.
Educational level relative to gender (Ν=28)
13th Annual Interdisciplinary Research Conference
Medical Audit.
Self-reported cognitive and emotional effects and lifestyle changes shortly after preventive cardiovascular consultations in general practice Dea Kehler.
Introduction Patients with tumors affecting the spine have significant impairments in Quality of Life domains that include physical function, neural function,
Exploring the SF-36, V2: Measuring the Quality of Life of AgrAbility Program Participants Ronald C. Jester Robert A. Wilson University of Delaware National.
Do We Need to Screen our IBD Patients for Depression: The Prevalence and Severity of Depression within a Typical DGH Cohort of IBD Patients N. Swart 1,
Quality Of Life, Health And Well Being Of Highly Active Individuals Louisa Raisbeck, Jeanne Johnston, Joel Stager, Francoise Benay Human Performance Laboratory,
PROMIS ® : Advancing the Science of PRO measurement Common Data Elements NIH CDE Webinar September 8, 2015 Ashley Wilder Smith, PhD, MPH Chief, Outcomes.
Introduction to the Patient-Reported Outcomes Measurement Information System (PROMIS) UCLA Center for East-West Medicine 2428 Santa Monica Blvd., Suite.
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
Long-term functional deficiencies of ICU-acquired weakness: a prospective study I Patsaki, G Sidiras, V Gerovasili, A Kouvarakos, E Polimerou, G Mitsiou,
Reliability and validity of the adapted Spanish version of the Early Onset Scoliosis-24 questionnaire María del Mar Pozo-Balado, PhD Hiroko Matsumoto PhD.
Sick Leave in Patients with Chronic Pain due to Occupational Injury in an Employer-Financed Work-Injury Compensation System Sandy Lee, J Yap, PP Chen Pain.
Psychosocial difficulties in head and neck cancer; the development of an evidence based measurement instrument Lucy Ziegler Rob Newell.
Presented by Dr. Vivek Indramohan Faculty of Health / CHSCR BCU Evaluating student experiences when undertaking an objective structured clinical examination.
PT 142 – Assessment in Physical Therapy Prepared by: Almira A. Tagala-Manuel, PTRP Prepared by ATM for PT 142 students AY
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Quality of Life After Treatment of Laryngeal.
Smart Bidding: tips & advice on securing UK national funding Prof Shea Palmer Professor of Musculoskeletal Rehabilitation.
DEVELOPING AND TESTING THE STANDARD OF PRACTICE AND EVALUATION OF CRITICAL-CARE-NURSING TOOL (SPECT) FOR GRADUATES OF CRITICAL CARE NURSE EDUCATION PROGRAMS.
Quantification of dyspnea using descriptors: Development and initial testing of the Dyspnea-12 J Yorke, S H Moosavi, C Shuldham, P W Jones (Thorax
Results Background Objectives Methods Conclusions
Development of an electronic personal assessment questionnaire to capture the impact of living with a vascular condition: ePAQ-VAS Patrick Phillips, Elizabeth.
Proportion of patients reporting scores ≥age-matched and gender-matched normative PRO values at baseline and 24 weeks in the (A) AMBITION and (B) ADACTA.
Progressive Multiple Sclerosis and incontinence:
Rhematoid Rthritis Respiratory disorders
Psychosocial Correlates of Symptoms in Functional Dyspepsia
Mean changes in the Short Form-36 subscales from baseline values for combined pulmonary fibrosis and emphysema (CPFE) (n=16), and chronic obstructive pulmonary.
Ronald C. Jester Robert A. Wilson University of Delaware
Health-Related Quality-of-Life Measures: Evidence from Tunisian Population Using the SF-12 Health Survey  Moheddine Younsi, PhD  Value in Health Regional.
The Impact of Pain Management on Quality of Life
Postoperative pain after abdominal hysterectomy: a randomized, double-blind, controlled trial comparing continuous infusion vs patient-controlled intraperitoneal.
Effects of deep hypothermic circulatory arrest on outcome after resection of ascending aortic aneurysm  Franz F Immer, MD, Hanna Barmettler, MD, Pascal.
Poorer sleep quality among adult patients with pectus excavatum in Taiwan: A pilot study  Yeung-Leung Cheng, MD, PhD, Chou-Chin Lan, MD, PhD, Yao-Kuang.
Responsiveness and clinically important differences for the WOMAC and SF-36 after hip joint replacement  J.M. Quintana, Ph.D., A. Escobar, M.D., A. Bilbao,
Quantity of clot lysed after catheter-directed thrombolysis for iliofemoral deep venous thrombosis correlates with postthrombotic morbidity  Nina K. Grewal,
Mu Qin et al. JACEP 2017;j.jacep
(A) Quality of life scores in individuals with and without constipation. (A) Quality of life scores in individuals with and without constipation. (B) Quality.
Correlations between observed patient-reported outcomes and disease activity scores at week 24. Correlations between observed patient-reported outcomes.
Health-related quality of life in survivors of open ruptured abdominal aortic aneurysm repair: A matched, controlled cohort study  Andrew B. Hill, MDCM,
Seth D. Crockett, Quinn K. Lippmann, Evan S. Dellon, Nicholas J
Health-Related Quality of Life in Patients Attending a Gastroenterology Outpatient Clinic: Functional Disorders Versus Organic Diseases  Magnus Simrén,
SF-36 domain scores at baseline and 24 weeks compared with age-matched and gender-matched normative values in the (A) AMBITION and (B) ADACTA trial populations.
Status of Patients Presently Living 9 to 13 Years After Orthotopic Heart Transplantation  Roland Hetzer, Wolfgang Albert, Manfred Hummel, Miralem Pasic,
ID Dr. Natālija Nikrus, Dr. Maija Vikmane, Prof. Oskars Kalējs
Mean individual and summative SF-36 V2 scores before and 3 months after ablation. Mean individual and summative SF-36 V2 scores before and 3 months after.
Percentages of patients reporting improvements from baseline ≥minimum clinically important difference (MCID) and number needed to treat (NNT) in (A) patient-reported.
Mean Short-Form 36 (SF-36) domain scores at baseline and 6 months in patients receiving active or placebo corticosteroids, cDMARDs or TNFis. Mean Short-Form.
Spydergram of mean SF-36 domain scores at baseline and weeks 12 (A) and 24 (B) for sarilumab 150 mg and 200 mg+csDMARDs compared with placebo+csDMARDs.
Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment  Ralf W. Sprengers, MD, Martin Teraa,
Spider plot of the unstandardised SF-36v2 subscales, comparing our HCM population with the mean for the general population (aged 45–54 years). Spider plot.
J. J. Smith, FRCS, A. M. Garratt, PhD, M. Guest, FRCS, R. M
Proportion of patients reporting improvements from baseline in patient-reported outcomes (PROs) ≥ the MCID at (A) 16 weeks in OPTION, (B) 12 weeks in BREVACTA.
Post hoc analysis of differences from placebo in the percentage of patients reporting improvements ≥MCID at week 24. Post hoc analysis of differences from.
Presentation transcript:

Development and initial validation of the ‘Bristol Impact of Hypermobility’ (BIoH) questionnaire ST Palmer a, F Cramp a, R Lewis b, G Gould c, E Clark c a Department of Allied Health Professions, University of the West of England, Bristol, UK. b Department of Physiotherapy, North Bristol NHS Trust, UK. c Musculoskeletal Research Unit, University of Bristol, UK. Background: Joint Hypermobility Syndrome (JHS) is a heritable disorder associated with pain and excessive joint range of motion in the absence of inflammatory joint disease. Symptomatic joint hypermobility has been reported to affect approximately 5% of women and 0.6% of men 1. The impact of JHS on individuals with the condition is currently not well understood but anecdotal evidence suggested that existing outcome measures fail to capture many of the difficulties encountered. Development of a condition-specific questionnaire was considered necessary to support clinical practice and future research into the impact and management of JHS. Aims: 1. To identify the impact of JHS in adults; 2. To develop a questionnaire to assess its impact; 3. To establish the concurrent validity of the new questionnaire against the Short Form (36) Health Survey (SF-36). Methods: Adults meeting the Brighton criteria for JHS were invited to take part in focus groups and semi- structured telephone interviews to explore the impact of the condition. Focus groups and interviews were recorded, transcribed verbatim and anonymised. Open coding of the transcripts was used to identify individual questionnaire items, discussed in detail and verified by two researchers (GG and SP). Thematic analysis of the data did not progress beyond this first level of coding as the aim was limited to identification of individual items. The specific wording of individual questions and response options for the draft questionnaire were discussed in detail and agreed by a working group comprising patient research partners and members of the research team. The draft questionnaire and SF-36 were then distributed by mail to 1,502 adult members of the Hypermobility Syndromes Association (HMSA). Completed questionnaires informed a systematic and iterative process of question removal on the basis of low median reported severity ( 0.7). The total score of the finalised questionnaire was then correlated against SF-36 responses by calculating Spearman's Rank correlation coefficients. Results: Focus group (two groups, total n=12) and telephone interview (n=3) participants comprised 2 men and 13 women aged years. The resultant draft questionnaire contained 94 scored items addressing issues such as pain, fatigue, physical function, anxiety, planning and management, and strength and weakness. n=624 valid questionnaires were returned from HMSA members (median age 39 years, 95% female). 39 questions were removed on the basis of low median reported severity and/or high correlations with other questions. The final 'Bristol Impact of Hypermobility' (BIoH) questionnaire contains 55 scored items and gives a maximum score of 360, with higher scores representing more severe impact. 88% and 53% of the cohort were below general population norms for the SF-36 Physical Component Score (PCS) and Mental Component Score (MCS) respectively. Correlations with individual component scores are presented in Table 1. Table 1. Correlation between total BIoH scores and individual components of the SF-36 (*all p<0.05). Conclusions: The BIoH questionnaire is the first condition-specific tool developed for JHS. It correlates strongly against the Physical Component Score (PCS) of the SF-36. Other psychometric properties of the questionnaire such as test-retest reliability and sensitivity to change are yet to be established. The questionnaire has demonstrated initial potential to inform future research and clinical practice in this under-recognised and poorly treated painful condition. References:1. Simpson MR (2006) Benign joint hypermobility syndrome: evaluation, diagnosis, and management. J Am Osteopath Assoc Clin Pract, 106(9): Funding: North Bristol NHS Trust Flexibility & Sustainability Fund and the University of the West of England, Faculty of Health & Life Sciences. Ethical Approval: South West 5 Research Ethics Committee (10/H0107/46).  Physical Component Score (PCS) -0.72*Mental Component Score (MCS) -0.45* Physical Functioning (PF) Role Physical (RP) Bodily Pain (BP) General Health (GH) -0.77* -0.75* -0.78* -0.57* Vitality (VT) Social Functioning (SF) Role Emotional (RE) Mental Health (MH) -0.63* -0.72* -0.47* -0.45*